| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 1998;65:787-792
© 1998 The Society of Thoracic Surgeons
Department of Thoracic and Cardiovascular Surgery, The Cleveland Clinic Foundation, Cleveland, Ohio, USA
Department of Gastroenterology, The Cleveland Clinic Foundation, Cleveland, Ohio, USA
Department of Hematology and Medical Oncology, The Cleveland Clinic Foundation, Cleveland, Ohio, USA
Department of Biostatistics and Epidemiology, The Cleveland Clinic Foundation, Cleveland, Ohio, USA
Department of Anatomic Pathology, The Cleveland Clinic Foundation, Cleveland, Ohio, USA
Dr Rice, The Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH 44195 (e-mail: ricet@cesmtp.ccf.org).
Presented at the Forty-fourth Annual Meeting of the Southern Thoracic Surgical Association, Naples, FL, Nov 6–8, 1997.
Background. The depth of tumor invasion (T) and regional lymph node status (N) are two factors that define the stage of an esophageal carcinoma. However, the arrangement of staging groups assumes that these factors are independent variables. A retrospective review of 359 consecutive patients undergoing esophageal resection was conducted to define the relationship between T and N and to determine whether T is a significant predictor of regional lymph node metastasis (N1).
Methods. Primary treatment was operation without preoperative therapy. There were 295 (82%) adenocarcinomas, 55 (15%) squamous cell carcinomas, and 9 (3%) adenosquamous carcinomas. T status was Tis in 29 (8%) patients, T1 in 65 (18%), T2 in 37 (10%), T3 in 219 (61%), and T4 in 9 (3%). N status was N0 in 161 (45%) patients and N1 in 198 (55%). M status was M0 in 327 (91%) patients and M1 in 32 (9%). Stage was 0 in 29 (8%) patients, I in 58 (16%), IIA in 70 (20%), IIB in 22 (6%), III in 148 (41%), and IV in 32 (9%).
Results. The likelihood of N1 disease occurring with increasing T was tested using the trend test. The percentage of patients with N1 disease is 0% for Tis, 11% for T1, 43% for T2, 77% for T3, and 67% for T4 (p < 0.001). This relationship existed for both adenocarcinoma and squamous cell carcinoma. Multivariable analysis identified increasing T, adenocarcinoma, and lack of well-differentiated histologic features as significant predictors of N1 disease. Compared with a T1 patient, a T2 patient is 6 times more likely to have N1 disease, a T3 patient 23 times, and a T4 patient 35 times.
Conclusions. We conclude that for patients with esophageal carcinoma, T is an important predictor of N and this association should be included with other established factors used in clinical staging and treatment decisions.
This article has been cited by other articles:
|
|
 |
|
  Y. M. Bhat, E. E. Furth, C. M. Brensinger, and G. G. Ginsberg Endoscopic resection with ligation using a multi-band mucosectomy system in Barrett's esophagus with high-grade dysplasia and intramucosal carcinoma Therapeutic Advances in Gastroenterology, November 1, 2009; 2(6): 323 - 330. [Abstract] [PDF]
|
|
|
|
 |
|
 H. Ishwaran, E. H. Blackstone, C. Apperson-Hansen, and T. W. Rice A novel approach to cancer staging: application to esophageal cancer Biostat., October 1, 2009; 10(4): 603 - 620. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Yajin, G. Murakami, H. Takeuchi, T. Hasegawa, and H. Kitano The normal configuration and interindividual differences in intramural lymphatic vessels of the esophagus. J. Thorac. Cardiovasc. Surg., June 1, 2009; 137(6): 1406 - 1414. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. DeMeester New Options for the Therapy of Barrett's High-Grade Dysplasia and Intramucosal Adenocarcinoma: Endoscopic Mucosal Resection and Ablation versus Vagal-Sparing Esophagectomy Ann. Thorac. Surg., February 1, 2008; 85(2): S747 - S750. [Full Text] [PDF]
|
|
|
|
|
|
S. Rampado, P. Bocus, G. Battaglia, A. Ruol, G. Portale, and E. Ancona Endoscopic Ultrasound: Accuracy in Staging Superficial Carcinomas of the Esophagus Ann. Thorac. Surg., January 1, 2008; 85(1): 251 - 256. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. H. Kang, Y. T. Kim, S.-H. Jeon, S.-W. Sung, and J. H. Kim Lymphadenectomy extent is closely related to long-term survival in esophageal cancer Eur. J. Cardiothorac. Surg., February 1, 2007; 31(2): 154 - 160. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. W. Rice, D. P. Mason, S. C. Murthy, G. Zuccaro Jr, D. J. Adelstein, L. A. Rybicki, and E. H. Blackstone T2N0M0 esophageal cancer J. Thorac. Cardiovasc. Surg., February 1, 2007; 133(2): 317 - 324. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Lagarde, F. J.W. ten Kate, J. B. Reitsma, O. R.C. Busch, and J. J. B. van Lanschot Prognostic Factors in Adenocarcinoma of the Esophagus or Gastroesophageal Junction J. Clin. Oncol., September 10, 2006; 24(26): 4347 - 4355. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Maish and S. R. DeMeester Endoscopic Mucosal Resection as a Staging Technique to Determine the Depth of Invasion of Esophageal Adenocarcinoma Ann. Thorac. Surg., November 1, 2004; 78(5): 1777 - 1782. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. C. Malaisrie, B. Untch, G. V. Aranha, N. Mohideen, A. Hantel, and J. Pickleman Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Cancer: Experience at a Single Institution Arch Surg, May 1, 2004; 139(5): 532 - 539. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. DeMeester Lymph node involvement in esophageal adenocarcinoma: if you see one, have you seen them all? J. Thorac. Cardiovasc. Surg., October 1, 2003; 126(4): 947 - 949. [Full Text] [PDF]
|
|
|
|
|
|
T. Lerut, W. Coosemans, G. Decker, P. De Leyn, N. Ectors, S. Fieuws, J. Moons, P. Nafteux, and D. Van Raemdonck Extracapsular lymph node involvement is a negative prognostic factor in T3 adenocarcinoma of the distal esophagus and gastroesophageal junction J. Thorac. Cardiovasc. Surg., October 1, 2003; 126(4): 1121 - 1127. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kuge, G. Murakami, S. Mizobuchi, Y. Hata, T. Aikou, and S. Sasaguri Submucosal territory of the direct lymphatic drainage system to the thoracic duct in the human esophagus J. Thorac. Cardiovasc. Surg., June 1, 2003; 125(6): 1343 - 1349. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. W. Rice, E. H. Blackstone, D. J. Adelstein, G. Zuccaro Jr, J. J. Vargo, J. R. Goldblum, S. C. Murthy, M. M. DeCamp, and L. A. Rybicki Role of clinically determined depth of tumor invasion in the treatment of esophageal carcinoma J. Thorac. Cardiovasc. Surg., May 1, 2003; 125(5): 1091 - 1102. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Krasna, X. Jiao, J. R. Sonett, Z. Gamliel, A. Eslami, Y. Raefaly, and Y. Mao Thoracoscopic and laparoscopic lymph node staging in esophageal cancer: do clinicopathological factors affect the outcome? Ann. Thorac. Surg., June 1, 2002; 73(6): 1710 - 1713. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. H. Blackstone and T. W. Rice Clinical-pathologic conference: Use and choice of statistical methods for the clinical study, ""Superficial adenocarcinoma of the esophagus"" J. Thorac. Cardiovasc. Surg., December 1, 2001; 122(6): 1063 - 1076. [Full Text] [PDF]
|
|
|
|
|
|
T. W. Rice, E. H. Blackstone, J. R. Goldblum, M. M. DeCamp, S. C. Murthy, G. W. Falk, A. H. Ormsby, L. A. Rybicki, J. E. Richter, and D. J. Adelstein Superficial adenocarcinoma of the esophagus J. Thorac. Cardiovasc. Surg., December 1, 2001; 122(6): 1077 - 1090. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Hagen and T. R. DeMeester Esophageal adenocarcinoma Ann. Thorac. Surg., October 1, 2001; 72(4): 1430 - 1432. [Full Text] [PDF]
|
|
|
|
|
|
M. J. Krasna, C. E. Reed, D. Nedzwiecki, D. R. Hollis, J. D. Luketich, M. M. DeCamp, R. J. Mayer, and D. J. Sugarbaker CALGB 9380: a prospective trial of the feasibility of thoracoscopy/laparoscopy in staging esophageal cancer Ann. Thorac. Surg., April 1, 2001; 71(4): 1073 - 1079. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-P. Hsu, C.-Y. Chen, J.-Y. Hsia, and S.-E. Shai Prediction of prognosis by the extent of lymph node involvement in squamous cell carcinoma of the thoracic esophagus Eur. J. Cardiothorac. Surg., January 1, 2001; 19(1): 10 - 13. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Yasunaga, Y. Tabira, K. Nakano, S. Iida, N. Ichimaru, N. Nagamoto, and T. Sakaguchi Accelerated growth signals and low tumor-infiltrating lymphocyte levels predict poor outcome in T4 esophageal squamous cell carcinoma Ann. Thorac. Surg., November 1, 2000; 70(5): 1634 - 1640. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Flamen, A. Lerut, E. Van Cutsem, W. De Wever, M. Peeters, S. Stroobants, P. Dupont, G. Bormans, M. Hiele, P. De Leyn, et al. Utility of Positron Emission Tomography for the Staging of Patients With Potentially Operable Esophageal Carcinoma J. Clin. Oncol., September 18, 2000; 18(18): 3202 - 3210. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Nishimaki, O. Tanaka, N. Ando, H. Ide, H. Watanabe, M. Shinoda, W. Takiyama, H. Yamana, K. Ishida, K. Isono, et al. Evaluation of the accuracy of preoperative staging in thoracic esophageal cancer Ann. Thorac. Surg., December 1, 1999; 68(6): 2059 - 2064. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Nigro, S. R. DeMeester, J. A. Hagen, T. R. DeMeester, J. H. Peters, M. Kiyabu, G. M. R. Campos, S. Oberg, O. Gastal, P. F. Crookes, et al. NODE STATUS IN TRANSMURAL ESOPHAGEAL ADENOCARCINOMA AND OUTCOME AFTER EN BLOC ESOPHAGECTOMY J. Thorac. Cardiovasc. Surg., May 1, 1999; 117(5): 960 - 968. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Reed Surgical Management of Esophageal Carcinoma Oncologist, April 1, 1999; 4(2): 95 - 105. [Abstract] [Full Text]
|
|
|
|
|
|
C. E. Reed, G. Mishra, A. V. Sahai, B. J. Hoffman, and R. H. Hawes Esophageal cancer staging: improved accuracy by endoscopic ultrasound of celiac lymph nodes Ann. Thorac. Surg., February 1, 1999; 67(2): 319 - 321. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Nigro, J. A. Hagen, T. R. DeMeester, S. R. DeMeester, J. H. Peters, S. Oberg, J. Theisen, M. Kiyabu, P. F. Crookes, and C. G. Bremner PREVALENCE AND LOCATION OF NODAL METASTASES IN DISTAL ESOPHAGEAL ADENOCARCINOMA CONFINED TO THE WALL: IMPLICATIONS FOR THERAPY J. Thorac. Cardiovasc. Surg., January 1, 1999; 117(1): 16 - 25. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. W. Rice COMMENTARY: ESOPHAGEAL CARCINOMA CONFINED TO THE WALL—THE NEED FOR IMMEDIATE DEFINITIVE THERAPY J. Thorac. Cardiovasc. Surg., January 1, 1999; 117(1): 26 - 27. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
